The collaboration seeks to leverage AI to enhance the precision and effectiveness of heart disease detection and monitoring, according to an Aug. 8 news release from SandboxAQ.
Under the collaboration, Mayo Clinic researchers will evaluate SandboxAQ’s MCG imaging system, known as CardiAQ. This mobile device utilizes magnetic sensors and advanced AI algorithms to offer rapid, radiation-free visualization of the heart’s magnetic signals.
The partnership’s initial phase will focus on a clinical study comparing MCG data with angiography findings and will be conducted at Mayo Clinic throughout 2024 and 2025. The study aims to explore the potential of MCG technology in improving cardiac diagnostics, according to the release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
